Carina Biotech
PrivateLast Round
Early Funding
Apr 15, 2025
Total Funding Raised
$14.58M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Carina Biotech is a biotechnology company that researches and develops chimeric antigen receptor T cell (CAR-T) therapies to treat solid cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Precision Medicine, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carina Biotech Comparables
Compare Carina Biotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Invectys | 80% | |
| AffyImmune Therapeutics | 78% | |
| A2 Biotherapeutics | 77% |
Carina Biotech Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Apr 15, 2025 | ||||
| Series A | Aug 15, 2022 | ||||
| Early Funding | Sep 1, 2021 | ||||
| Grant | Apr 23, 2020 |
Carina Biotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Minderoo Foundation | Series A, Early Funding |
| University of Adelaide | Series A |
| Tenmile | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 34% MoM, reaching 3.2K.
- Dec 22, 2025
Grew 19% QoQ, from 16 to 19 employees.
Carina Biotech Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Carina Biotech's valuation, stock price, and market status.
Is Carina Biotech a public or private company?
Carina Biotech is a private company.
What is the current stock price of Carina Biotech?
Carina Biotech is a private company with no public stock price. No recent secondary market data is available.
How much is Carina Biotech worth (valuation)?
Valuation information for Carina Biotech is not publicly available.
Can I buy Carina Biotech stock?
Carina Biotech shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Carina Biotech's last funding round?
Carina Biotech's most recent funding round was Early Funding on April 15, 2025.
Who are the main investors in Carina Biotech?
Key investors in Carina Biotech include Minderoo Foundation, Tenmile.
Will Carina Biotech IPO soon?
No public IPO plans have been announced for Carina Biotech.
How can I track Carina Biotech secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Carina Biotech's secondary market activity and sign up for updates.